Home » Topics » Disease categories and therapies » Dental

Dental
RSS

Acologix expands AC-100 phase II development for periodontal bone loss

May 30, 2005

Acologix advances AC-100 into phase II in dentistry

May 10, 2005

BioMimetic's GEM-21S recommended for approval

July 20, 2004

PMA for GEM-21S accepted for review

May 7, 2004

Enrollment under way in phase III Periostat MR study for adult periodontitis

April 13, 2004

BioMimetic Pharmaceuticals and Luitpold Pharmaceuticals establish alliance

Jan. 14, 2004

Inhibitors of Arg- and Lys-gingipain and their use in periodontitis therapy

June 20, 2003

Periostat approved in Canada

April 8, 2003

New data on subantimicrobial doses of Periostat discussed in San Antonio

March 25, 2003

Arestin approved in Sweden

Jan. 24, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...